BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gessi S, Poloni TE, Negro G, Varani K, Pasquini S, Vincenzi F, Borea PA, Merighi S. A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease. Cells 2021;10:2344. [PMID: 34571993 DOI: 10.3390/cells10092344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Franco R, Lillo A, Navarro G, Reyes-resina I. The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases. Expert Opinion on Therapeutic Targets 2022. [DOI: 10.1080/14728222.2022.2136570] [Reference Citation Analysis]
2 Saimaiti A, Zhou DD, Li J, Xiong RG, Gan RY, Huang SY, Shang A, Zhao CN, Li HY, Li HB. Dietary sources, health benefits, and risks of caffeine. Crit Rev Food Sci Nutr 2022;:1-19. [PMID: 35574653 DOI: 10.1080/10408398.2022.2074362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Merighi S, Nigro M, Travagli A, Pasquini S, Borea PA, Varani K, Vincenzi F, Gessi S. A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? Int J Mol Sci 2022;23:5056. [PMID: 35563447 DOI: 10.3390/ijms23095056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, Pasquini S, Suresh RR, Kim SW, Volkow ND, Jacobson KA, Gessi S. Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease. Molecules 2022;27:2680. [PMID: 35566035 DOI: 10.3390/molecules27092680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tang ML, Wen ZH, Wang JH, Wang ML, Zhang H, Liu XH, Jin L, Chang J. Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke. ACS Med Chem Lett 2022;13:436-42. [PMID: 35295085 DOI: 10.1021/acsmedchemlett.1c00599] [Reference Citation Analysis]